Research Funding
- NIH R01CA203737: Targeting human cancers with hemizygous deletion of TP53
- NIH R01CA206366: Nanotechnology enabled targeting of p53 deficiency in human cancer
- NIH R21CA213535: Engineering antibody drug conjugates to target p53-defective triple negative breast cancer
- NIH R21CA185742: Ubiquitin specific peptidases as redox sensor in oncogene-induced p53 signaling
- IU School of Medicine Strategic Research Initiative fund
- Vera Bradley Foundation fund
- Walter A. and Laura W. Deutsch Scholarship